Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Parving H-H et al. - Losartan treatment reduced renal outcomes in proteinuric patients with type 2 diabetes in the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) study. It is unknown whether an insertion (I)/deletion (D) polymorphism in the angiotensin I-converting enzyme (ACE) gene predicts renal outcomes and death and influences the effect of losartan in these patients...Proteinuric type 2 diabetic patients with the D allele of the ACE gene have an unfavorable renal prognosis, which can be mitigated and even improved by losartan

Related Articles

Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study
International Journal of Obesity, 10/16/09    Relevance Score: 84%

Increasing BMI and waist circumference and prevalence of obesity among adults with Type 2 diabetes: the National Health and Nutrition Examination Surveys
Journal of Diabetes and its Complications, 11/17/09    Relevance Score: 83%

Debating cancer and diabetes in Vienna
Practice Nursing, 11/10/09    Relevance Score: 83%

The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/09/09    Relevance Score: 83%

A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
Pharmacotherapy, 10/28/09    Relevance Score: 83%

Today in Basic Science/Genetics...keeping you current

Familiality of kidney stone disease in Iceland
Scandinavian Journal of Urology and Nephrology, 12/04/09

Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues
Journal of Cancer Research & Clinical Oncology, 12/03/09

Connective Tissue Growth Factor-(CTGF, CCN2) - A Marker, Mediator and Therapeutic Target for Renal Fibrosis
Nephron: Experimental Nephrology, 12/03/09

Today in Endocrinology...keeping you current

Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: A prospective evaluation
Urologic Oncology: Seminars and Original Investigations, 12/03/09

Response of Secondary Hyperparathyroidism to Cinacalcet Depends on Parathyroid Size
Nephron: Clinical Practice, 12/01/09

Stone composition and metabolic status
Urological Research - Urolithiasis, 11/25/09

Today in Nephropathies...keeping you current

Contrast induced nephropathy in urology
Indian Journal of Urology, 12/03/09

Expression of P311, a transforming growth factor beta latency-associated protein-binding protein, in human kidneys with IgA nephropathy
International Urology and Nephrology, 12/02/09

Does Arkadia contribute to TGF-[beta]1-induced IgA expression through up-regulation of Smad signaling in IgA nephropathy
International Urology and Nephrology, 12/02/09

Today in Pharmacology/kinetics...keeping you current

Medium-size-vessel vasculitis
Pediatric Nephrology, 12/04/09

Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: A prospective evaluation
Urologic Oncology: Seminars and Original Investigations, 12/03/09

Long-term graft function with tacrolimus and cyclosporine in renal transplantation: Paired kidney analysis
Nephrology, 12/03/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address